Interleukin-6 and tumor necrosis factor-α levels of endothelial cells in different hypoxia modes: In vitro experiment

National Medical Journal of China

Volumn 87, Issue 11, 2007, Pages 774-777

  Feng, Jing ^a   Chen, Bao Yuan ^b   Guo, Mei Nan ^b   Cao, Jie ^b   Zhao, Hai Yan ^b   Liang, Dong Chun ^b   Zuo, Ai Jun ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Cell hypoxia; Interleukin 6; Obstructive; Sleep apnea; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL HYPOXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERCAPNIA; IN VITRO STUDY; INFLAMMATION; PROTEIN EXPRESSION; REOXYGENATION; SLEEP APNEA SYNDROME; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

CELL HYPOXIA; CELL LINE; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249796407     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA, 2003, 290: 1906-1914.
2. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res, 2001, 89: 763-771.
3. 2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol, 2004, 96: 1173-1177.
4. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation, 2005, 112: 2660-2667.
5. Winnicki M, Shamsuzzaman A, Lanfranchi P, et al. Erythropoietin and obstructive sleep apnea. Am J Hypertens, 2004, 17: 783-786.
6. 2+/calmodulin kinase-dependent activation of hypoxia-inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem, 2005, 280: 4321-4328.